WUXI BIOLOGICS Ownership
| 1FW1 Stock | EUR 6.15 0.25 4.24% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
WUXI |
WUXI Stock Ownership Analysis
The company has Price/Earnings (P/E) ratio of 238.12. WUXI BIOLOGICS UNSPADR2 had not issued any dividends in recent years. WuXi Biologics Inc., an open-access biologics technology platform company, provides solutions to organizations to discover, develop, and manufacture biologics from concept to commercial manufacturing in the Peoples Republic of China, North America, Europe, and internationally. WuXi Biologics Inc. is a subsidiary of WuXi Biologics Holdings Limited. WUXI BIOLOGICS is traded on Frankfurt Stock Exchange in Germany. For more info on WUXI BIOLOGICS UNSPADR2 visit http://www.wuxibiologics.com.WUXI BIOLOGICS Outstanding Bonds
WUXI BIOLOGICS issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. WUXI BIOLOGICS UNSPADR2 uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most WUXI bonds can be classified according to their maturity, which is the date when WUXI BIOLOGICS UNSPADR2 has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| US98262PAA93 Corp BondUS98262PAA93 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in WUXI Stock
WUXI BIOLOGICS financial ratios help investors to determine whether WUXI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in WUXI with respect to the benefits of owning WUXI BIOLOGICS security.